Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Infections × Immunoglobulins, Intravenous × Clear all

Sponsor

Conditions

Neuroblastoma 1 Neoplasms, Plasma Cell 1 Multiple Myeloma 1 Limbic Encephalitis 1 Immunoglobulin Light-chain Amyloidosis 1 Hematologic Neoplasms 1 Epilepsy 1 Epilepsies, Partial 1 Drug Resistant Epilepsy 1 Autoimmune Diseases of the Nervous System 1 Autoimmune Diseases 1

Interventions

Daptomycin 2 threonic acid 1 telavancin 1 telaprevir 1 soybean oil, phospholipid emulsion 1 plerixafor 1 peginterferon alfa-2a 1 human papillomavirus vaccine, L1 type 16, 18 1 fludarabine phosphate 1 Whole-Body Irradiation 1 Voriconazole 1 Trimethoprim, Sulfamethoxazole Drug Combination 1 Trimethoprim 1 Tacrolimus 1 Sulfamethoxazole 1 Sirolimus 1 Ribavirin 1 Peripheral Blood Stem Cell Transplantation 1 Ofloxacin 1 Methotrexate 1 Melphalan 1 Magnesium Sulfate 1 Human Papillomavirus Recombinant Vaccine nonavalent 1 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1 Hematopoietic Stem Cell Transplantation 1 Granulocyte Colony-Stimulating Factor 1 Fluconazole 1 Filgrastim 1 Etoposide 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡